FOXP3 and chordoma: Zou analyzed two subtypes of T cells (CD8+ TILs and Foxp3+ TILs) in chordoma in 2018 and found that the ratio of CD8+ TILs to Foxp3+ TILs was 3.3 times and related to the patient’s overall survival (OS) (84).